Expert Rev Anti Infect Ther. 2009;7(8):967-980. Nafcillin is considered the intravenous treatment of choice for MSSA; however, many other intravenous agents such as cephalosporins, β-lactams and ...
As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...
Aptorum Group Announces Further Positive Data For Its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate For The Treatment of Infections Caused By Staphylococcus Aureus and On Track ...
A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the ...
(HealthDay News) — Invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections are more common than invasive methicillin-resistant Staphylococcus aureus (MRSA) infections, according to a ...
If the skin of a person’s nose becomes damaged, Staphylococcus aureus bacteria can enter the wound and cause an infection. Many people carry Staphylococcus aureus (S.aureus) on their skin or within ...